Article info

PDF

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Authors

  1. Correspondence to Sofia Dahlqvist; sofia.dahlqvist{at}hotmail.com
View Full Text

Citation

Dahlqvist S, Ahlén E, Filipsson K, et al
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Publication history

  • Received August 18, 2017
  • Revised January 8, 2018
  • Accepted January 27, 2018
  • First published February 24, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.